AzTrials
AzTrials

Physical FunctioningNCT07050589

Group Recreation to Enhance Function Aging

A study testing Exercise and art in people with Physical Functioning and Cognitive Functioning, run by State University of New York at Buffalo at 1 site in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Investigators will develop and deliver a community-based recreation program, delivering group artmaking and group SMARTfit dual-task exergaming to community-dwelling older adults. The program will be delivered through the Buffalo-Niagara YMCA. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Physical Functioning, Cognitive Functioning
What is being tested?
Exercise and art
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteUnited States
Study dates
15 Oct 2025to 1 Mar 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • > = 60 years of age
  • have no more than MCI (MoCA score ≥ 24 points)
  • have no contraindications to exercise, guided by the American College of Sports Medicine
  • fluent in English

Who cannot join

  • have a condition that would prevent safe participation in the exercise, as determined by the Physical Activity Readiness Questionnaire for Older Adults (PAR-OA);
  • have severe neurological disease
  • have severe psychiatric illness
  • have a likelihood of withdrawing from the study due to severe illness or a life expectancy of < 6 mo
  • have experienced a lower or upper limb amputation
  • have greater than mild cognitive impairment (MoCA score < 24 points).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Buffalo-Niagara YMCA

    Buffalo, New York, 14223

Other trials in United States

About this study

Official title: A Community-Based Recreation Program to Improve Function and Quality of Life in Older Adults

Investigators will develop and deliver a community-based recreation program, delivering group artmaking and group SMARTfit dual-task exergaming to community-dwelling older adults. The program will be delivered through the Buffalo-Niagara YMCA. Outcomes of interest are change in cognitive function and change in physical functioning, inresponse to 24 weeks of weekly training.

Being tested
Exercise and art
Keywords
walking, balance, strength, attention, memory, interference inhibition, dual-task, artmaking, exergaming

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Exercise and artBehavioural

    Weekly SMARTfit dual-task exergaming and group art-making

Study groups in NCT07050589
Study groupRoleWhat they receive
ProgramExperimentalProgram participants will receive the recreation-based program.
Receives: Behavioral: Exercise and art
ControlNo interventionControl participants will receive no recreation-based program.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognitive Function: Attention

    Change in performance on the Trail-Making Test

    Measured: From enrollment to week 8 and then week 16

Secondary outcomes (3)
  1. Balance

    Change in balance assessed by the Four Stage Balance Test

    Measured: From enrollment to week 8 and then week 16

  2. Dual-Task Performance

    Dual task performance assessed using the Timed Up and Go-Dual Task

    Measured: From enrollment to week 8 and then week 16

  3. Cognitive Function: Interference Inhibition

    Change in performance on the Stroop Test

    Measured: baseline to week 8, through week 16

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jul 2025
  2. Study start15 Oct 2025
  3. Primary completion1 Feb 2027 (estimated)
  4. Study completion1 Mar 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07050589
Sponsor's protocol ID
00008757
Status last verified
Mar 2026
First submitted
8 Apr 2025
Last updated
19 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Requests to access deidentified participant data can be submitted starting 12 months after article publication and the data will be made accessible for up to 12 months. Access to IPD can be requested by qualified researchers engaging in independent scientific research and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA). For more information or to submit a request, contact NS1@buffalo.edu.

Questions about this trial

What is this clinical trial studying?

A study testing Exercise and art in people with Physical Functioning and Cognitive Functioning, run by State University of New York at Buffalo at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognitive Function: Attention (time frame: From enrollment to week 8 and then week 16). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in